Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.
| Image |  |
|---|---|
| Description | scientific article published in August 2011 |
| Author/s |
author: Bingshu E. Chen Randy D Gascoyne |
| Publication date | August 1, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |